The unfavourable outcome associations observed by Fang et al were weakened or lost their significance after adjustment for CRP, suggesting that elevated BMI can affect melanoma progression through mechanisms related to metabolic syndrome and/or chronic systemic inflammation, as indicated by CRP concentration [18]. Here, CRP is linked to metabolic syndrome.